CN102181550A - 一种检测多种病原微生物的方法和试剂盒 - Google Patents
一种检测多种病原微生物的方法和试剂盒 Download PDFInfo
- Publication number
- CN102181550A CN102181550A CN201110097673XA CN201110097673A CN102181550A CN 102181550 A CN102181550 A CN 102181550A CN 201110097673X A CN201110097673X A CN 201110097673XA CN 201110097673 A CN201110097673 A CN 201110097673A CN 102181550 A CN102181550 A CN 102181550A
- Authority
- CN
- China
- Prior art keywords
- seq
- nucleotide sequence
- sequence shown
- risk
- risk hpv
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000000034 method Methods 0.000 title claims abstract description 49
- 244000000010 microbial pathogen Species 0.000 title claims abstract description 21
- 239000000523 sample Substances 0.000 claims abstract description 148
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 109
- 239000007787 solid Substances 0.000 claims abstract description 67
- 238000001514 detection method Methods 0.000 claims abstract description 42
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 claims abstract description 39
- 230000003321 amplification Effects 0.000 claims abstract description 26
- 238000003199 nucleic acid amplification method Methods 0.000 claims abstract description 26
- 238000009396 hybridization Methods 0.000 claims abstract description 24
- 229960002685 biotin Drugs 0.000 claims abstract description 19
- 235000020958 biotin Nutrition 0.000 claims abstract description 19
- 239000011616 biotin Substances 0.000 claims abstract description 19
- 108090001008 Avidin Proteins 0.000 claims abstract description 18
- 239000002773 nucleotide Substances 0.000 claims description 179
- 125000003729 nucleotide group Chemical group 0.000 claims description 179
- 241000701806 Human papillomavirus Species 0.000 claims description 78
- 238000012360 testing method Methods 0.000 claims description 60
- 239000000758 substrate Substances 0.000 claims description 40
- 102000004190 Enzymes Human genes 0.000 claims description 26
- 108090000790 Enzymes Proteins 0.000 claims description 26
- 239000003795 chemical substances by application Substances 0.000 claims description 19
- 238000011144 upstream manufacturing Methods 0.000 claims description 14
- 125000000962 organic group Chemical group 0.000 claims description 7
- 241001614291 Anoplistes Species 0.000 claims description 5
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims description 5
- SXRSQZLOMIGNAQ-UHFFFAOYSA-N Glutaraldehyde Chemical group O=CCCCC=O SXRSQZLOMIGNAQ-UHFFFAOYSA-N 0.000 claims description 5
- 229910052799 carbon Inorganic materials 0.000 claims description 5
- 238000000605 extraction Methods 0.000 claims description 5
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 claims description 5
- 108091003079 Bovine Serum Albumin Proteins 0.000 claims description 3
- 229940098773 bovine serum albumin Drugs 0.000 claims description 3
- 238000012120 genotypic test Methods 0.000 claims description 2
- 108020004414 DNA Proteins 0.000 abstract description 41
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract description 9
- 201000010099 disease Diseases 0.000 abstract description 8
- 238000003759 clinical diagnosis Methods 0.000 abstract description 6
- 102000004169 proteins and genes Human genes 0.000 abstract description 4
- 238000012216 screening Methods 0.000 abstract description 4
- 102000053602 DNA Human genes 0.000 abstract description 3
- 230000035945 sensitivity Effects 0.000 abstract description 2
- 230000001404 mediated effect Effects 0.000 abstract 1
- 239000007790 solid phase Substances 0.000 abstract 1
- 208000022361 Human papillomavirus infectious disease Diseases 0.000 description 109
- 230000008696 hypoxemic pulmonary vasoconstriction Effects 0.000 description 109
- 239000000243 solution Substances 0.000 description 37
- 238000006243 chemical reaction Methods 0.000 description 29
- 239000007788 liquid Substances 0.000 description 17
- 206010008342 Cervix carcinoma Diseases 0.000 description 9
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 9
- 208000006105 Uterine Cervical Neoplasms Diseases 0.000 description 9
- 201000010881 cervical cancer Diseases 0.000 description 9
- 238000002372 labelling Methods 0.000 description 9
- 108010001336 Horseradish Peroxidase Proteins 0.000 description 8
- 102000004160 Phosphoric Monoester Hydrolases Human genes 0.000 description 8
- 108090000608 Phosphoric Monoester Hydrolases Proteins 0.000 description 8
- 238000004925 denaturation Methods 0.000 description 7
- 230000036425 denaturation Effects 0.000 description 7
- 238000013461 design Methods 0.000 description 6
- 238000004519 manufacturing process Methods 0.000 description 6
- 230000001717 pathogenic effect Effects 0.000 description 6
- 239000000047 product Substances 0.000 description 6
- 239000003513 alkali Substances 0.000 description 5
- 239000002585 base Substances 0.000 description 5
- 239000000872 buffer Substances 0.000 description 5
- 238000005516 engineering process Methods 0.000 description 5
- 239000012634 fragment Substances 0.000 description 5
- 239000002504 physiological saline solution Substances 0.000 description 5
- 230000004044 response Effects 0.000 description 5
- 208000037581 Persistent Infection Diseases 0.000 description 4
- 241000700605 Viruses Species 0.000 description 4
- SXEHKFHPFVVDIR-UHFFFAOYSA-N [4-(4-hydrazinylphenyl)phenyl]hydrazine Chemical compound C1=CC(NN)=CC=C1C1=CC=C(NN)C=C1 SXEHKFHPFVVDIR-UHFFFAOYSA-N 0.000 description 4
- 125000003368 amide group Chemical group 0.000 description 4
- 208000015181 infectious disease Diseases 0.000 description 4
- HWYHZTIRURJOHG-UHFFFAOYSA-N luminol Chemical compound O=C1NNC(=O)C2=C1C(N)=CC=C2 HWYHZTIRURJOHG-UHFFFAOYSA-N 0.000 description 4
- 230000007170 pathology Effects 0.000 description 4
- 238000002360 preparation method Methods 0.000 description 4
- 238000012797 qualification Methods 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- 238000005406 washing Methods 0.000 description 4
- BCHIXGBGRHLSBE-UHFFFAOYSA-N (4-methyl-2-oxochromen-7-yl) dihydrogen phosphate Chemical compound C1=C(OP(O)(O)=O)C=CC2=C1OC(=O)C=C2C BCHIXGBGRHLSBE-UHFFFAOYSA-N 0.000 description 3
- 102000002260 Alkaline Phosphatase Human genes 0.000 description 3
- 108020004774 Alkaline Phosphatase Proteins 0.000 description 3
- 206010059313 Anogenital warts Diseases 0.000 description 3
- 241000972773 Aulopiformes Species 0.000 description 3
- 229920000742 Cotton Polymers 0.000 description 3
- 238000000018 DNA microarray Methods 0.000 description 3
- 101100450563 Mus musculus Serpind1 gene Proteins 0.000 description 3
- 238000003149 assay kit Methods 0.000 description 3
- 230000008859 change Effects 0.000 description 3
- 238000001502 gel electrophoresis Methods 0.000 description 3
- 150000002576 ketones Chemical class 0.000 description 3
- 238000012986 modification Methods 0.000 description 3
- 230000004048 modification Effects 0.000 description 3
- 238000004321 preservation Methods 0.000 description 3
- 235000019515 salmon Nutrition 0.000 description 3
- 238000005070 sampling Methods 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- ZGZLYKUHYXFIIO-UHFFFAOYSA-N 5-nitro-2h-tetrazole Chemical compound [O-][N+](=O)C=1N=NNN=1 ZGZLYKUHYXFIIO-UHFFFAOYSA-N 0.000 description 2
- 206010008263 Cervical dysplasia Diseases 0.000 description 2
- 238000007400 DNA extraction Methods 0.000 description 2
- NCAHSINAPUWCBE-UHFFFAOYSA-N O.O.O.O.O.O.P(=O)(O)(O)O.[N+](=O)([O-])C1=CC=C(C=C1)[Na] Chemical compound O.O.O.O.O.O.P(=O)(O)(O)O.[N+](=O)([O-])C1=CC=C(C=C1)[Na] NCAHSINAPUWCBE-UHFFFAOYSA-N 0.000 description 2
- 108091034117 Oligonucleotide Proteins 0.000 description 2
- 241000233855 Orchidaceae Species 0.000 description 2
- 241001631646 Papillomaviridae Species 0.000 description 2
- 241000246358 Thymus Species 0.000 description 2
- 235000007303 Thymus vulgaris Nutrition 0.000 description 2
- 230000002159 abnormal effect Effects 0.000 description 2
- 208000007951 cervical intraepithelial neoplasia Diseases 0.000 description 2
- 238000005660 chlorination reaction Methods 0.000 description 2
- 239000011248 coating agent Substances 0.000 description 2
- 238000000576 coating method Methods 0.000 description 2
- 230000002380 cytological effect Effects 0.000 description 2
- 238000003745 diagnosis Methods 0.000 description 2
- 239000012153 distilled water Substances 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 238000006911 enzymatic reaction Methods 0.000 description 2
- 210000000981 epithelium Anatomy 0.000 description 2
- 239000007850 fluorescent dye Substances 0.000 description 2
- 210000004392 genitalia Anatomy 0.000 description 2
- 230000003118 histopathologic effect Effects 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 230000003902 lesion Effects 0.000 description 2
- UPSFMJHZUCSEHU-JYGUBCOQSA-N n-[(2s,3r,4r,5s,6r)-2-[(2r,3s,4r,5r,6s)-5-acetamido-4-hydroxy-2-(hydroxymethyl)-6-(4-methyl-2-oxochromen-7-yl)oxyoxan-3-yl]oxy-4,5-dihydroxy-6-(hydroxymethyl)oxan-3-yl]acetamide Chemical compound CC(=O)N[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@H]1[C@H](O)[C@@H](NC(C)=O)[C@H](OC=2C=C3OC(=O)C=C(C)C3=CC=2)O[C@@H]1CO UPSFMJHZUCSEHU-JYGUBCOQSA-N 0.000 description 2
- 230000001575 pathological effect Effects 0.000 description 2
- 150000003014 phosphoric acid esters Chemical class 0.000 description 2
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 2
- 238000012545 processing Methods 0.000 description 2
- 238000004153 renaturation Methods 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 201000010153 skin papilloma Diseases 0.000 description 2
- 238000011895 specific detection Methods 0.000 description 2
- 239000006228 supernatant Substances 0.000 description 2
- 230000009182 swimming Effects 0.000 description 2
- PRZSXZWFJHEZBJ-UHFFFAOYSA-N thymol blue Chemical compound C1=C(O)C(C(C)C)=CC(C2(C3=CC=CC=C3S(=O)(=O)O2)C=2C(=CC(O)=C(C(C)C)C=2)C)=C1C PRZSXZWFJHEZBJ-UHFFFAOYSA-N 0.000 description 2
- 239000001585 thymus vulgaris Substances 0.000 description 2
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 1
- 208000030507 AIDS Diseases 0.000 description 1
- WFDIJRYMOXRFFG-UHFFFAOYSA-N Acetic anhydride Chemical compound CC(=O)OC(C)=O WFDIJRYMOXRFFG-UHFFFAOYSA-N 0.000 description 1
- 108020004635 Complementary DNA Proteins 0.000 description 1
- 208000001490 Dengue Diseases 0.000 description 1
- 206010012310 Dengue fever Diseases 0.000 description 1
- 240000001624 Espostoa lanata Species 0.000 description 1
- 235000009161 Espostoa lanata Nutrition 0.000 description 1
- 241000711549 Hepacivirus C Species 0.000 description 1
- 208000005176 Hepatitis C Diseases 0.000 description 1
- 241000701044 Human gammaherpesvirus 4 Species 0.000 description 1
- 102000014150 Interferons Human genes 0.000 description 1
- 108010050904 Interferons Proteins 0.000 description 1
- 241000780272 Mammilla Species 0.000 description 1
- 206010028119 Mucosal membrane hyperplasia Diseases 0.000 description 1
- 241000187479 Mycobacterium tuberculosis Species 0.000 description 1
- 108020005187 Oligonucleotide Probes Proteins 0.000 description 1
- 241000283973 Oryctolagus cuniculus Species 0.000 description 1
- 238000012408 PCR amplification Methods 0.000 description 1
- 241000224016 Plasmodium Species 0.000 description 1
- 108020004682 Single-Stranded DNA Proteins 0.000 description 1
- 241000934136 Verruca Species 0.000 description 1
- 229930003756 Vitamin B7 Natural products 0.000 description 1
- 208000000260 Warts Diseases 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000001464 adherent effect Effects 0.000 description 1
- 238000000246 agarose gel electrophoresis Methods 0.000 description 1
- 150000001299 aldehydes Chemical class 0.000 description 1
- 238000005576 amination reaction Methods 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 239000000427 antigen Substances 0.000 description 1
- 102000036639 antigens Human genes 0.000 description 1
- 108091007433 antigens Proteins 0.000 description 1
- 230000027455 binding Effects 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 239000007853 buffer solution Substances 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-N carbonic acid Chemical compound OC(O)=O BVKZGUZCCUSVTD-UHFFFAOYSA-N 0.000 description 1
- 238000006555 catalytic reaction Methods 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 238000001311 chemical methods and process Methods 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 201000004196 common wart Diseases 0.000 description 1
- 239000002299 complementary DNA Substances 0.000 description 1
- 239000013068 control sample Substances 0.000 description 1
- 238000013016 damping Methods 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 208000025729 dengue disease Diseases 0.000 description 1
- GYZLOYUZLJXAJU-UHFFFAOYSA-N diglycidyl ether Chemical compound C1OC1COCC1CO1 GYZLOYUZLJXAJU-UHFFFAOYSA-N 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000000539 dimer Substances 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 210000002919 epithelial cell Anatomy 0.000 description 1
- 125000003700 epoxy group Chemical group 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 238000007654 immersion Methods 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 229940079322 interferon Drugs 0.000 description 1
- 150000004702 methyl esters Chemical class 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 210000004400 mucous membrane Anatomy 0.000 description 1
- 239000013642 negative control Substances 0.000 description 1
- 230000009871 nonspecific binding Effects 0.000 description 1
- 239000002751 oligonucleotide probe Substances 0.000 description 1
- 229920000620 organic polymer Polymers 0.000 description 1
- 239000013641 positive control Substances 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 238000005215 recombination Methods 0.000 description 1
- 230000006798 recombination Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 238000012552 review Methods 0.000 description 1
- 230000003248 secreting effect Effects 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 238000003805 vibration mixing Methods 0.000 description 1
- 235000011912 vitamin B7 Nutrition 0.000 description 1
- 239000011735 vitamin B7 Substances 0.000 description 1
Images
Landscapes
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
Description
Claims (13)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201110097673.XA CN102181550B (zh) | 2011-04-18 | 2011-04-18 | 一种检测多种病原微生物的方法和试剂盒 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201110097673.XA CN102181550B (zh) | 2011-04-18 | 2011-04-18 | 一种检测多种病原微生物的方法和试剂盒 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN102181550A true CN102181550A (zh) | 2011-09-14 |
CN102181550B CN102181550B (zh) | 2014-07-09 |
Family
ID=44567837
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201110097673.XA Active CN102181550B (zh) | 2011-04-18 | 2011-04-18 | 一种检测多种病原微生物的方法和试剂盒 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN102181550B (zh) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107850597A (zh) * | 2015-08-11 | 2018-03-27 | 豪夫迈·罗氏有限公司 | 用于免疫测定的细小病毒的碱预处理 |
Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6352825B1 (en) * | 1994-02-21 | 2002-03-05 | Stichting Researchfonds Pathologie | Human Papilloma Virus detection in a nucleic acid amplification process using general primers |
US20040121426A1 (en) * | 2002-12-18 | 2004-06-24 | Palo Alto Research Center Incorporated | Process for preparing albumin protein conjugated oligonucleotide probes |
US20050175989A1 (en) * | 2001-06-20 | 2005-08-11 | Ching-Yu Lin | Method and detector for identifying subtypes of human papilloma viruses |
CA2502742A1 (en) * | 2005-04-04 | 2006-10-04 | Xianghai Chen | Quantifiable mirror microarray detecting nucleic acid targets and methods for production and test thereof |
CN101035896A (zh) * | 2004-10-04 | 2007-09-12 | 固德基因公司 | 人乳头瘤病毒探针和包含其的dna芯片 |
CN101437963A (zh) * | 2006-03-03 | 2009-05-20 | 真进生物株式会社 | 用寡核苷酸微球阵列检测人乳头瘤病毒的试剂盒和方法 |
CN201280550Y (zh) * | 2008-05-15 | 2009-07-29 | 港龙生物技术(深圳)有限公司 | 一种高通量基因检测与分型的微孔板装置 |
CN101792819A (zh) * | 2009-12-17 | 2010-08-04 | 陕西北美基因股份有限公司 | 高通量可目视化人乳头瘤病毒基因芯片快速分型检测方法 |
-
2011
- 2011-04-18 CN CN201110097673.XA patent/CN102181550B/zh active Active
Patent Citations (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6352825B1 (en) * | 1994-02-21 | 2002-03-05 | Stichting Researchfonds Pathologie | Human Papilloma Virus detection in a nucleic acid amplification process using general primers |
US20050175989A1 (en) * | 2001-06-20 | 2005-08-11 | Ching-Yu Lin | Method and detector for identifying subtypes of human papilloma viruses |
US20070031827A1 (en) * | 2001-06-20 | 2007-02-08 | Ching-Yu Lin | Method and detector for identifying subtypes of human papilloma viruses |
US20040121426A1 (en) * | 2002-12-18 | 2004-06-24 | Palo Alto Research Center Incorporated | Process for preparing albumin protein conjugated oligonucleotide probes |
CN101035896A (zh) * | 2004-10-04 | 2007-09-12 | 固德基因公司 | 人乳头瘤病毒探针和包含其的dna芯片 |
CA2502742A1 (en) * | 2005-04-04 | 2006-10-04 | Xianghai Chen | Quantifiable mirror microarray detecting nucleic acid targets and methods for production and test thereof |
CN101437963A (zh) * | 2006-03-03 | 2009-05-20 | 真进生物株式会社 | 用寡核苷酸微球阵列检测人乳头瘤病毒的试剂盒和方法 |
CN201280550Y (zh) * | 2008-05-15 | 2009-07-29 | 港龙生物技术(深圳)有限公司 | 一种高通量基因检测与分型的微孔板装置 |
CN101792819A (zh) * | 2009-12-17 | 2010-08-04 | 陕西北美基因股份有限公司 | 高通量可目视化人乳头瘤病毒基因芯片快速分型检测方法 |
Non-Patent Citations (2)
Title |
---|
P. E. GRAVITT,ET AL: "Improved Amplification of Genital Human papillomaviruses", 《JOURNAL OF CLINICAL MICROBILOLGY》 * |
王晶等: "基因芯片法与杂交捕获法检测人乳头瘤病毒对比分析", 《中国肿瘤临床》 * |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107850597A (zh) * | 2015-08-11 | 2018-03-27 | 豪夫迈·罗氏有限公司 | 用于免疫测定的细小病毒的碱预处理 |
CN107850597B (zh) * | 2015-08-11 | 2021-06-04 | 豪夫迈·罗氏有限公司 | 用于免疫测定的细小病毒的碱预处理 |
Also Published As
Publication number | Publication date |
---|---|
CN102181550B (zh) | 2014-07-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Bodaghi et al. | Could human papillomaviruses be spread through blood? | |
Abreu et al. | A review of methods for detect human Papillomavirus infection | |
CN102994651B (zh) | 用于18种高危型人乳头瘤病毒荧光pcr检测的引物和探针及其试剂盒 | |
Randhawa et al. | DNA sequencing of viral capsid protein VP-1 region in patients with BK virus interstitial nephritis | |
CN102985565B (zh) | 人乳头状瘤病毒的快速基因型鉴定分析及其装置 | |
Tarragó et al. | Different cytomegalovirus glycoprotein B genotype distribution in serum and cerebrospinal fluid specimens determined by a novel multiplex nested PCR | |
CN101017141A (zh) | 诊断人类乳头状病毒(hpv)感染的荧光聚合酶链式反应(pcr)的方法和试剂盒 | |
JP4358637B2 (ja) | ヒトパピローマウイルスを検出しタイプを特定するための増幅−ハイブリダイゼーション方法 | |
CN107177699A (zh) | 一种人类乳头瘤病毒(hpv)分型快速检测方法 | |
US8455632B2 (en) | Primer set and probe for detection of human papillomavirus | |
WO2007084567A2 (en) | Detection and discrimination of hepatitis c virus, human immunodeficiency virus type-1 and hepatitis b virus | |
CN102102131A (zh) | 检测单纯疱疹病毒ⅱ型荧光pcr试剂盒 | |
CN101613764B (zh) | 一种高危型hpv荧光pcr筛查方法及引物、探针和试剂盒 | |
Oh et al. | Polymerase chain reaction‐based fluorescent Luminex assay to detect the presence of human papillomavirus types | |
Bible et al. | Cervical lesions are associated with human papillomavirus type 16 intratypic variants that have high transcriptional activity and increased usage of common mammalian codons | |
CN102703606B (zh) | Hr-hpv e6/e7基因snp检测的固相芯片和探针以及检测试剂盒 | |
CN104232800A (zh) | 检测猪流行性乙型脑炎病毒、猪瘟病毒和猪繁殖与呼吸综合征病毒的基因芯片以及试剂盒 | |
CN106048081A (zh) | 一种hpv分型检测引物及其检测方法和应用 | |
CN104293981A (zh) | 检测猪流行性乙型脑炎病毒和/或猪瘟病毒的基因芯片以及试剂盒 | |
CN102181550B (zh) | 一种检测多种病原微生物的方法和试剂盒 | |
CN104293976A (zh) | 检测猪流行性乙型脑炎病毒和/或猪繁殖与呼吸综合征病毒的基因芯片以及试剂盒 | |
Lee et al. | Comparison of human papillomavirus detection and typing by hybrid capture 2, linear array, DNA chip, and cycle sequencing in cervical swab samples | |
CN101824487B (zh) | Pcr结合核酸探针斑点杂交技术检测病料中病毒感染 | |
RU2532344C2 (ru) | Способ диагностики гиперпролиферативных состояний и оценки риска развития рака шейки матки при цервикальной интраэпителиальной неоплазии и папилломавирусном носительстве на основе определения уровней мрнк функционального комплекса генов человека | |
CN101386892B (zh) | 一种出入境检疫中常见病毒联合检测分型基因芯片及其检测方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: Method and kit for detecting multiple pathogenic microorganisms Effective date of registration: 20200313 Granted publication date: 20140709 Pledgee: Shenzhen hi tech investment small loan Co.,Ltd. Pledgor: SHENZHEN KANGMEI BIOTECHNOLOGY Co.,Ltd. Registration number: Y2020980000702 |
|
PC01 | Cancellation of the registration of the contract for pledge of patent right |
Date of cancellation: 20210924 Granted publication date: 20140709 Pledgee: Shenzhen hi tech investment small loan Co.,Ltd. Pledgor: SHENZHEN KANGMEI BIOTECHNOLOGY Co.,Ltd. Registration number: Y2020980000702 |
|
PC01 | Cancellation of the registration of the contract for pledge of patent right | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: Method and kit for detecting multiple pathogenic microorganisms Effective date of registration: 20210927 Granted publication date: 20140709 Pledgee: Shenzhen hi tech investment small loan Co.,Ltd. Pledgor: SHENZHEN KANGMEI BIOTECHNOLOGY Co.,Ltd. Registration number: Y2021980009992 |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
PC01 | Cancellation of the registration of the contract for pledge of patent right |
Date of cancellation: 20230428 Granted publication date: 20140709 Pledgee: Shenzhen hi tech investment small loan Co.,Ltd. Pledgor: SHENZHEN KANGMEI BIOTECHNOLOGY Co.,Ltd. Registration number: Y2021980009992 |
|
PC01 | Cancellation of the registration of the contract for pledge of patent right |